Yahoo

Givaudan (SWX:GIVN) Stock Gets Fair Value Bump After Higher Analyst Growth Views

Trade JPM on Coinbase

Givaudan is back in focus after fair value estimates moved from CHF 3,468.45 to CHF 3,604.81, a shift that puts fresh attention on where the stock might sit within the current range of price targets. Recent moves from banks such as J.P. Morgan and Barclays, with targets stretching from CHF 2,886 to CHF 3,850, highlight how divided analysts are on the risk and reward profile. In the sections that follow, you will see how these updates fit together and how to keep track of the evolving Givaudan story.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Givaudan.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

  • Several firms have raised their price targets on Givaudan in recent months. Deutsche Bank moved from CHF 3,300 to CHF 3,650 in July 2026, then to CHF 3,700 in early September, and keeps a Buy rating, which points to confidence in the company's ability to execute on its current plan.

  • J.P. Morgan increased its target from CHF 3,600 to CHF 3,700 and maintains an Overweight view. This signals that the firm sees the current valuation as supported by Givaudan's position in fragrances and flavours.

  • Barclays upgraded Givaudan to Overweight in October 2026 and lifted its target from CHF 3,450 to CHF 3,850. The research highlights what it views as an attractive risk and reward profile and expects concerns around fine fragrance market share to ease in the second half of the year.

🐻 Bearish Takeaways

  • Jefferies moved Givaudan to Hold from Buy in September 2026 and cut its target from CHF 3,700 to CHF 3,030. The firm points to Fine Fragrance, where it sees the premiumization advantage fading, which could weigh on growth expectations if that view plays out.

  • Bernstein initiated coverage in July 2026 with an Underperform rating and a CHF 2,886 target. Its research cites sector rotation and slower growth in ingredients companies, which it sees as a risk for Givaudan's long term rerating potential.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!

SWX:GIVN 1-Year Stock Price Chart
SWX:GIVN 1-Year Stock Price Chart

We've flagged 1 risk for Givaudan. See which could impact your investment.

How This Changes the Fair Value For Givaudan

  • Fair Value has moved from CHF 3,468.45 to CHF 3,604.81, an increase of about 4.0%.

  • Revenue Growth has been revised from 3.87% to 5.65%.

  • Net Profit Margin has shifted from 15.10% to 15.00%.

  • Future P/E has moved from 28.0x to about 28.8x.

  • The Discount Rate has edged from 4.27% to 4.26%.

Never Miss an Update: Follow The Narrative

Narratives tie Givaudan's business story to analyst forecasts and fair value in one place. They update automatically when new research, risks or company developments are added.

Head over to the Simply Wall St Community and follow the Narrative on Givaudan to stay up to date on:

  • How growth in emerging markets such as India, Brazil, the Middle East and China, together with a focus on local and regional clients, feeds into expectations for ongoing organic revenue gains.

  • Why new sustainable and natural ingredients, plus investments in biotechnology and digital product tools, are central to analyst views on Givaudan's future margins and customer reach.

  • Which headwinds, including margin pressure from input costs and tariffs, negative free cash flow periods, antitrust investigations and softer demand in Fragrance Ingredients, are flagged as key risks to the current story.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include GIVN.SW .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: